CA2111925C - Thermoplastic polyurethanes modified by siloxane block copolymers - Google Patents

Thermoplastic polyurethanes modified by siloxane block copolymers Download PDF

Info

Publication number
CA2111925C
CA2111925C CA002111925A CA2111925A CA2111925C CA 2111925 C CA2111925 C CA 2111925C CA 002111925 A CA002111925 A CA 002111925A CA 2111925 A CA2111925 A CA 2111925A CA 2111925 C CA2111925 C CA 2111925C
Authority
CA
Canada
Prior art keywords
thermoplastic polyurethanes
segmented thermoplastic
integer
diol
component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002111925A
Other languages
French (fr)
Other versions
CA2111925A1 (en
Inventor
Heinz Pudleiner
Herbert Hugl
Rolf Dhein
Hanns-Peter Muller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of CA2111925A1 publication Critical patent/CA2111925A1/en
Application granted granted Critical
Publication of CA2111925C publication Critical patent/CA2111925C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/42Block-or graft-polymers containing polysiloxane sequences
    • C08G77/458Block-or graft-polymers containing polysiloxane sequences containing polyurethane sequences
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/08Processes
    • C08G18/10Prepolymer processes involving reaction of isocyanates or isothiocyanates with compounds having active hydrogen in a first reaction step
    • C08G18/12Prepolymer processes involving reaction of isocyanates or isothiocyanates with compounds having active hydrogen in a first reaction step using two or more compounds having active hydrogen in the first polymerisation step
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40High-molecular-weight compounds
    • C08G18/4009Two or more macromolecular compounds not provided for in one single group of groups C08G18/42 - C08G18/64
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40High-molecular-weight compounds
    • C08G18/61Polysiloxanes

Abstract

The invention relates to thermoplastic polyurethanes modified with segmented siloxane block copolymers which are based on relatively high molecular weight dihydroxy compounds, diisocyanates, and difunctional chain extenders. The application also relates to their use in the medical field, and particularly as a catheter material.

Description

Mo-4027 LeA 29,463 THERMOPLASTIC POLYURETHANES
MODIFIED BY SILOXANE BLOCK COPOLYMERS
BACKGROUND OF THE INVENTION
This invention relates to thermoplastic polyurethanes modified by siloxane block copolymers, to a process far their production, and to catheters produced therefrom.
Thermoplastic polyurethane elastomers (TPU's) have long been known. They are of commercial significance by virtue of their combi-nation of excellent mechanical properties with the known advantages of inexpensive thermoplastic processability. A wide range of mechan-ical properties can be established through the use of different chemi-cal synthesis components. A review of TPU's, their properties and their applications can be found, for example, in Kunststoffe 68 (1978), pages 819 to 825 and in Kautschuk, Gummi, Kunststoffe 35 (1982), pages 568 to 584.
Various attempts have already been made to produce TPU's which exhibit the unique surface properties of polysiloxanes, such as, for example, water repellency, anti-adhesive properties, compatibility with blood, reduced abrasion and reduced hardness. TPU's with these surface properties are desirable.
One method is to mix TPU's with polysiloxanes. On account of the poor compatibility of polysiloxanes with synthetic polymers, the siloxanes have to be modified. One possibility is to use siloxanes containing vinyl-polymerizable double bonds as described in, for ~ , example, Japanese Patent 59/78236; 1984. According to U.S. Patent 4,675,361 (believed to be an equivalent to British Patent A
2,140,438), polyurethanes containing polydialkyl siloxanes are used s:lksIIDB0176 Le A 29,463-US/CA

-2- ~a1 ~.~.~~~
as additives for blood-compatible base polymers. Only hydroxyalkyl-terminated siloxanes are mentioned as non-polar soft segments. The disadvantage of such a compound lies in the large quantity of polysiioxane needed to improve the surface properties. In addition, the production process of such a compound is very complicated.
Another possible solution which has already been described lies in the use of the soft polysiloxane as a non-polar soft segment in a thermoplastically processable elastomer (see Japanese Patent 601252 617, and U.S. Patent 4,518,758). Due to the high molecular weight of the siioxane components, a considerable quantity of siloxane has to be used. However, this high siloxane content disturbs the phase morphology to such an extent that the mechanical proper-ties of the elastomer deteriorate.
U.S. Patent 3,562,352 describes polysiloxane-containing block copolymers in which polysiloxane blocks and polyurethane blocks are directly attached to one another by Si-N bonds. However, the materi als produced are not thermoplastic polyurethanes.
In addition, U.S. Patent 4,647,643 describes non-blocking soft polyurethanes containing from 1 to 15% by weight of polyoxy-alkylenelsiloxane block copolymers. These materials are also de-scribed as non-tacky and non-toxic, and may be suitable for medical equipment, such as tubes, blood bags and implants.
The hardness of TPU's produced from Linear polyhydroxy com pounds, diisocyanates and diols is adjusted through the content of so called hard phase which consists essentially of diisocyanate and short-chain diols. In practice; however, the production of TPU's having relatively low hardness is complicated by sticking in the ma Mo4027 Le A 29,463 -3- ~',~ :~_:~
chine and by poor demoldability. TPU's having relatively low hard-ness generally also suffer from reduced mechanical properties and increased compression set values.
The incorporation of isocyanates consisting of various geomet-ric isomers, for example 4,4'-bis-(isocyanatocyclohexyl)-methane, has a particularly unfavorable effect in soft thermaplastic polyurethanes.
The TPU's produced from these types of isomers generally consist of very slowly recrystallizing hard segments and, accordingly, give products with poor demolding properties.
The most significant thermoplastic polyurethanes used in the medical field are aromatic TPU's. It is suspected that in the use of these aromatic TPU's that, unless processing is optimal, 4,4"-bis-(aminophenyl)-methane (i.e. MDA) is formed after long-term use (i.e.
more than 30 days). Although there are also cycloaliphatic TPU's which do not have this problem, they nevertheless present processing difficulties due to the poorly recrystallizing hard segments. The surface tackiness values shown in Table 2 were measured by com-parison with known cycloaliphatic TPU's.
In addition, thermoplastic polyurethanes are ideally suitable for biomedical applications, and particularly for catheters. Since cathe-ters are inserted into the body, the ideal catheter should have above all a high bending modules, shear modules or high rigidity at room temperature.
This applies in particular to intravenous catheters which are directly inserted into the bloodstream through the skin. Since ease of insertion is particularly important for the placing of the catheter, intra-venous catheters are made of high-modules materials, such as, for example, polytetrafluoroethylene, poly(chlorotrifluoroethylene), fluori-nated ethylenelpropylene copolymer or the like. However, when the Mo4027 Le A 29,463 - 4 - ~, .~ ~. ~. 9 catheter is placed in the correct position in the vein, its rigidity or high modulus level is a disadvantage. The rigidity of the catheter can result in damage to the inner wail of the blood vessels by the tip of the catheter.
A very soft, rubber-like material would be less likely to damage the inner wall of the blood vessels. It could also be left in the vein for a longer period without having to be replaced or repositioned else-where. However, a flexible catheter with these advantages would not be so easy to insert into the body. Accordingly, there is a need for a catheter which can be easily inserted into and positioned in the blood-stream without damaging the inner walls of blood vessels.
The ideal catheter composition has a high modulus or rigidity at room temperature during the insertion and positioning phase of the catheter, and softens in the bloodstream at body temperature. This preliminary softening process should take place as quickly as possible in order to minimize the above-described risk of damage within the blood vessels. hiowever, the catheter should not soften to such an extent that the material used loses most of its mechanical strength, as this would pose a danger of parts of the catheter remaining in the blood-stream and blood vessels in the event of failure of the material upon removal of the catheter.
Various methods have already been adopted to achieve the preliminary softening at body temperature.
Water-absorbing polyurethanes are known from U.S. Patent 3,822,238. They are produced from polymers with a low carbon to oxygen to nitrogen ratio, or polymer chains containing quaternary ammonium or salt-containing groups and small quantities of isocyanate. According to the patent, these polymers may be used as coatings or membranes or may be formed by casting into body Mo4027 Le A 29,463 _5_ implants. Of the many polymers claimed, there is not one that would be particularly suitable for medical implants. In addition, the proper-ties which polymers for implants are required to exhibit are not men-tinned.
It is known from U.S. Patent 3,975,350 that hydrophilic crosslinked polyurethane systems can be useful as supports for drug release, as coatings or for implants, such as catheters and cannulas.
However, there is no mention of which polyurathanes would be useful for implants.
U.S. Patent 4,454,309 describes a polymer mixture consisting of a hydrophilic polyurethane and a polyolefin from the group of polyalkyl esters and polyacrylic acid esters. This mixture is said to be suitable for a number of applications, including catheters and can-nulas.
PCT WO 86/01813 describes multi-phase polymer mixtures consisting of a non-hydrophilic polymer, such as polyurethane for example, and a hydrophilic polymer component. The softening and swelling of the polymer mixture by absorption of water are described as advantages of these mixtures. In the event of complete hydration measured after 24 h, a softening ratio of 2:1 is achieved.
Polymer blends preferably consisting of phenoxy resin as plasticizer and polyester urethanes with selected softening tempera-tures between room temperature and 62°C are known from European Patent 422,693. These mixtures are proposed as suitable materials -for medical articles.
The described systems have certain disadvantages. Thus, most polymers cannot form catheters by standard methods because they are not thermoplastic materials. However, the main disadvan-tage is that the materials are~softened by absorption of water.
Mo4027 Le A 29,463 This process is controlled by diffusion and, accordingly, takes much longer than softening due to an increase in temperature.
Accordingly, softening by the increase from room temperature to body temperature seems more advantageous. In addition, multi-phase systems such as those described hereinabove generally lack optical transparency.
Beyond the known properties of siloxane components modified by polyurethane surfaces, none of the above references describe the polyurethanes claimed in the present invention with the surprising property of softening of body temperature. In addition, the described processes are unsuitable for the production of catheters by thermo-plastic processing techniques known per se. The incorporation of polysiloxanes, particularly in soft plastics with hardness values below 100 Shore A, is aimed at the anti-blocking properties after extrusion or injection molding. It could not be expected from the teaching of U.S. Patent 4,647,643 that siloxane block copolymers would also be suitable for meeting the needs mentioned above.
Accordingly, the problem addressed by the present invention was to economically combine the favorable mechanics! properties of a TPU with the particular properties of a polysiloxane to obtain thermoplastically processable products which would be easier to process than the cycloaliphatic TPU's of the prior art and which, in addition, would soften at body temperature.
DESCRIPTION OF THE INVENTION
The present invention relates to segmented thermoplastic polyurethanes modified with siloxane block copolymers and based pn relatively high molecular weight dihydroxy compounds, diisocyanates, and difunctional chain extenders. These segmented thermoplastic Mo4027 Le A 29,463 polyurethanes modified wish siloxane block copolymers comprise the reaction product of a) a relatively high molecular weight dihydroxy compound having a molecular weight of from 800 to 8,000, and preferably in the range from 1,000 to 4,000;
b) at least one isocyanate corresponding to the general formula:
OCN-Z-NCO, wherein Z represents: a difunctional organic radical;
c) at least one difunctional chain extender;
and d) at least one substantially linear hydroxy-terminated polyol corresponding to the following formula:
O
0 ii H 0- RZ-IC 0-(CNz)= Si -0 Si-(CHZ)=-0 C-RZ-O r-1 (1~
x x ..
wherein x represents: an integer of from 1 to 30, y represents: an integer of from 1 to 50, z represents: an integer of from 2 to 4, R' represents: a C,,~ alkyl group or a phenyl group, and RZ represents: a C2~ alkylene group.
The substantially linear hydroxyl-terminated polyol is preferably a polyether, a polycarbonate, or mixtures thereof, and preferably has a molecular weight in the range of from 1,000 to 4,000.
The difunctional chain extenders are preferably aliphatic diols having from 2 to 14 carbon atoms or cycloaliphatic diamines having, from 2 to 14 carbon atoms. Particularly preferred chain extenders include ethylene glycol, butane diol, hexane diol, 1,4-di-(b-Mo4027 %e/ . G
Izydroxyethyl)-hydroquinone and isophorone diamine, 4,4'-dicyclohexylmeihane diamine.
TPU's can be produced continuously or discontinuously. The most well-known production processes are the so-called belt process and the extruder process which are also applied on an industrial scale.
The present invention also relates to a process for the produc-tion of the thermoplastic polyurethane elastomers according to the invention, in which synthesis components a) to d) are reacted, option-ally in the presence of catalysts, auxiliaries andlor additives, in quanti-ties such that the equivalent ratio of NCO groups of the diiso-cyanates to the sum of the NCO-reactive groups of components a), c) and d) is between 0.85 and 1.2:1, and preferably between 0.95 and 1.1:1.
Suitable polyetherols for the invention can be produced by reacting one or more alkylene oxides containing 2 to 4 carbon atoms in the alkylene radical with a starter molecule containing two active hydrogen atoms in bound form. Suitable alkylene oxides include, for example, ethylene oxide, 1,2-propylene oxide, epichlorohydrin and 1,2- and 2,3-butylene oxide. Ethylene oxide, propylene oxide and mixtures of 1,2-propylene oxide and ethylene oxide are preferably used. The alkylene oxides may be used individually, alternately one after the other, or in the form of mixtures. Suitable starter molecules include, for example, water, aminoalcohols, such as, for example, N-alkyl diethanoiamines, such as, for example, N-methyl diethanol-amine, and diols, such as, for example, ethylene glycol, 1,3-propylene glycol, butane-1,4-diol and hexane-1,6-diol. Mixtures of starter mole-cules may also be used. Other preferred polyetherots include the hydroxyfunctional polymerization products of tetrahydrofuran.
Le A 29,463 -g- is The substantially linear polyetherols have molecular weights in the range from 800 to 8,000 and, more preferably, in the range from 1,000 to 4,000. They may be used both individually, and in the form of mixtures with one another.
Suitable polyesterols may be produced, for example, from CZ_,a and preferably C4,~ carboxylic acids and polyhydric alcohols. Suitable dicarboxyiic acids include, for example, aliphatic dicarboxylic acids, such as, for example, succinic acid, glutaric acid, adipic acid, suberic acid, azelaic acid and sebacic acid, and aromatic dicarboxylic acids, such as, for example, phthalic acid, isophthalic acid and terephthalic acid. The dicarboxylic acids may be used either individually or in the form of mixtures, for example, in the form of a mixture of succinic, glutaric and adipic acid. To produce the polyesterols, it may be of ad-vantage to use the corresponding dicarboxylic acid derivatives instead of dicarboxylic acids, such as, far example, carboxylic acid diesters containing 1 to 4 carbon atoms in the alcohol radical, carboxylic anhydrides or carboxylic acid chlorides. Examples of polyhydric alcohols include giycols containing from 2 to 10, and preferably 2 to 6 carbon atoms, such as, for example, ethylene glycol, diethylene glycol, butane-1,4-diol, pentane-1;5-diol, hexane-1,6-diol, decane-1,10-diol, 2,2-dimethylpropane-1,3-diof, propane-1,3-diol and dipropylene glycol. Depending on the required properties, the polyhydric alcohols may be used individually or even in admixture with one another.
Esters of carbonic acid with the diols mentioned hereinabove, particularly diols containing 4 to 6 carbon atoms, such as, for exam-ple, butane-1,4-diol and/or hexane-1,6-diol, condensates of w-hy-droxycarboxylic acids, for example w-hydroxycarboxylic acid, and Mo4027 Le A 29,463 preferably polymerization products of lactones, for example, optionally substituted w-caprolactones, are also preferred.
Particularly preferred polyesterols are butane-1,4-diol poly-adipates, hexane-1,6-diol neopentyl glycol polyadipates, hexane-1,6-diol/butane-1,4-diol polyadipates, polycaprolactones and hexane diol polycarbonate.
The polyesterols have molecular weights in the range from 800 to 8,000 and preferably in the range from 1,000 to 4,000.
Suitable organic diisocyanates b) include, for example, aliphatic and cycloaliphatic diisocyanates, of which the following are mentioned by way of example: aliphatic diisocyanates, such as hexamethylene diisocyanate, and cycloaliphatic diisocyanates, such as isophorone diisocyanate, 1,4-cyclohexane diisocyanate, 1-methyl-2,4- and -2,6-cyclohexane diisocyanate and the corresponding isomer mixtures, 4,4'-, 2,4'- and 2,2'-dicyclohexyi methane diisocyanate and the corre sponding isomer mixtures. Cycloaliphatic diisocyanates are preferred.
Suitable compaunds to be used as the chain extending agents, component c), include difunctional compounds such as, for example, aliphatic diols and aliphatic, cycloaliphatic, and aromatic diamines.
These chain-extending agents preferably have molecular wejghts in the range from 60 to 300. Suitable aliphatic diols preferably contain from 2 to 14 carbon atoms and include compounds such as, for example, ethane diol, hexane-1,6-diol, dimethytene glycol, dipropylene glycol and butane-1,4-diol. Other suitable chain-extending agents include the diesters of terephthalic acid With glycols containing 2 to 4 carbon atoms such as, for example, terephthalic acid bisethylene glycol or butane-1,4-diol; hydroxyalkylene ethers of hydroquinone such as, for example, 1,4-di-(t3-hydroxyethyl)-hydroquinone.
Mo4027 Le A 29,463 It is also possible to use difunctional diamines as the chain extending agent. Suitable difunctional diamines include, for example, aliphatic diamines such as, for example, ethylene diamine, 1,2- and 1,3-propylene diamine, N-methyl-1,3-propylene diamine, and N,N'-dimethyl ethylene diamine; cycloaliphatic diamines such as, for example, iso-phorone diamine; and aromatic diamines such as, for example, 2,4- and 2,6-tolylene diamine, 3,5-diethyl-2,4- and/or -2,6-tolylene diamine and primary ortho-, di-, tri- and/or tetra-alkyl substituted 4,4'-diaminodiphenyl urethanes. It is particularly preferred to use butane-1,4-diol as component c).
To adjust the hardness and melting point of the TPU's, the molar ratios in which components a), c), and d) are used may be varied within relatively wide limits. Molar ratios of polyhydroxyl compounds a) and d) to chain-extending agents c) of from 1:1 to 1:12 and, more particularly, from 1:1.8 to 1:4.4 have proved to be suitable. The hardness and melting point of the TPU's increases as the quantity of chain extending agent increases.
It is possible to produce products having hardness values in the range from 70 Shore A to 75 Shore D, and, more particularly, in the range from 70 Shore A to 55 Shore D.
To produce the TPU's, the synthesis components a) to d) may be reacted, optionally in the presence of catalysts, auxiliaries and/or additives d), in such quantities that the equivalent ratio of NCO groups of the diisocyanates to the sum of the NCO-reactive groups, particularly the OH
groups, of components a), c), and d) is 1:0.85 to 1.20 and preferably 1:0.95 to 1:1.1.
Mo4027 Le A 29,463 -11a-In a process for the production of the modified thermoplastic polyurethanes of the present invention, components a), b), c) and d) may be reacted either in stages or by a one-shot process. The process may optionally be in the presence of catalysts and/or additives. Typically, the ratio of NCO groups of the diisocyanates to the sum of the NCO-reactive groups in components a), c) and d) is from 1:0.85 to about 1:1.2.
Mo4027 Le A 29,463 ~,~~.:~2J
-t2-Suitable catalysts, which in particular accelerate the reaction between the NCO groups of the diisocyanates b) and the isocyanate reactive groups of synthesis components a), c) and d), are the tertiary amines known from the prior art such as, for example, triethyl amine, dimethyl cyclohexyl amine, N-methyl morpholine, N,N'-dimethyl piperazine, 2-(dimethylaminoethoxy)-ethanol, diazabicyclo-(2,2,2)-octane, and the like and, in particular, organometallic compounds, such as, for exam- ...
ple, titanic acid esters, iron compounds, tin compounds, such as, for example, tin diacetate, tin dioctoate, tin dilaurate, or the tin dialkyl salts of aliphatic carboxylic acids, such as, for example, dibutyl tin diacetate, dibutyl tin dilaurate or the like. The catalysts are typically used in quantities of 0.005 to 0.1 part to 100 parts polyhydroxyl com-pound.
In addition to catalysts, auxiliaries and/or additives be incorporated in the synthesis components, examples of suitable auxiliaries andlor additives include lubricants, inhibitors, stabilizers against hydrolysis, light, heat and discoloration, tlameproofing agents, dyes, pigments, inorganic and/or organic fillers and reinforcing materi-als.
Further particulars of the auxiliaries and additives mentioned hereinabove can be found in the literature, for example in J.H.
Saunders and K.C. Frisch: "High Polymers", Vol. XVI, Polyurethanes, Parts 1 and 2, Interscience Publishers, 1962 and 1964 and in DE-A
29 01 774.
Mo4027 Le A 29,463 Polysiloxane/polyiactone block copolymers corresponding to Formula I are known products and may be produced by methods known per se. A silane corresponding to Formula (II):
R' R' t I

H- -Si---0 --Si----H (Il) R' R' Y

wherein y represents: an integer of from 1 to 50 R' represents: a C1-6alkyl group or a phenyl group is reacted in a ratio of 1:2 with an unsaturated, aliphatic or cycloaliphatic alcohol such as, for example, allyl alcohol, buten-1-of or penten-1-of in the presence of a catalyst such as, for example, hexachloroplatinic acid. Various quantities of caprolacione, g-butyrolactone or e-valerolactone or mixtures thereof can be added onto the bifunctional hydroxy-terminated polydimethy! siloxane in the presence of a tin octoate catalyst, where the ratio by weight of ~5 siloxane to lactone is determined by the block length of the lactone.
Products such as these are commercially available from Th.
Goldschmidt (Essen) under the names of Tegomer 6110, 6120, 6140 and 6160. Tegomers are bifunctional hydroxy-terminated polycapro-lactone-poly(dimethyl siloxane)-polycaprolactone triblock copolymers.
Common bifunctional hydroxy-terminated nonblock polydimethylsiloxa,~es are _ unnuscible (incompatible) with the other synthesis components, so that there is insufftent incorporation of the polydimethylsiloxane into the polymer back bone, which leads to low molecular weight and poor mechanical properties, such as tensile stren~th"
elongation, ' compression set. The good mechanical properties of the polymers of the present invention, ~~ contain up to 20 %a by weight of the siloxane blockcopolymer, give evidence for the incorporation of this component into the polymer.
In addition, the block structure of the siloxane copolymer improves compatibility with the ocher TPU components during the synthesis process and facilitates incorporation of the siloxane copoly-mer.
Le A 29,463 The reduction in surface tackiness, as a function of time, of the TPU's produced in the Examples by comparison with a commercial product based on cycloaliphatic TPU's is shown in Table 2.
As can readily be seen, the surface tackiness of the melt assumes virtually its final value after only about 1.5 minutes in the case of the TPU's according to the invention. By contrast, the siloxane-free TPU's (i.e. comparisons) remain tacky for up to about 6 minutes while those containing standard siloxane (also comparison) only reach the final level after about 3.5 minutes starting from a low level.
Suitable processes for the production of the modified polyurethanes of the present invention include reacting the components in stages or by a one-shot process. The reaction typically occurs at an NCO:OH ratio of 1:0.85 to 1:1.2.
The polyurethane of the present invention, which can also be processed for example in mixtures with other thermoplastics and elastomers by injection molding, extrusion, coating and fiber production, may be used in the medical field by virtue of its surface properties (i.e.
compatibility with blood). The material is particularly suitable for catheters.
The invention is further illustrated by the following Examples and Tables. The invention, which is set forth in the foregoing disclosure, is not to be limited either in spirit or scope by these examples. Those skilled in the art will readily understand that known variations of the conditions of the following procedures can be used. Unless otherwise noted, all temperatures are degrees Celsius and all parts are parts by weight.
Mo4027 Le A 29,463 ~~' ~. I~. ~ ~e~

c a~
N

W

w Q

f ~' '-' L1 ' O d ~ C U

(~pO~pO U ~ O'D
p d_ OO~NO ~
O O C~
C
N
~
N

N ~ , C

~ ~ w E ~
a~
~L
~
~' C
C
C

0 C cb O O b (0 w ~.
m N
o ( ~ ~ tB O t~1 O ~ d a O ( N N ~ ~
U
O

O _ o O > ~ _ O
a~ O
1-"- ~ m 'co ~m h ~.v-f-~

>. v N
~
~
~
Wit;

~ O
N
O
O

~ ~ v ~ ~ >.
V
r r M
r s ~ ~ f0 b r r r ~ .N
~L
o E

~
N
O

Q
U

~ ~ r-~ ~ U U
X

!lJ '. j y, J C cv O O

d0 ~ ' ~~ m E C O U O
C

.Q ', V
~

C T~ ~ X
tt9 ~ ~ ~
~ -0 ~
0 j U m ~' p 'OZO [ , ~ a ~Il ~

O O ef .a C 'A O
.t~ U V C~ CUB ~Q>?, s UJ r 7. t d.

C ~ _ ~ ~ '~ m ~ctf N N ~ ~ ~ ~ O ~ 3 '"i ~ ~ s t' .C O ' O
M
~

C ~ O
a d X ~

. N ''. t1f ~y N '~
N Q
N ~
~
N

U c~ O .c ~
W

~ _ (' l~ p.~ H p.
_ (flnDO ~~_tOr-O

N ~ _ M P ' I17 r .a S7 a:
l0 O N

~~ (n ~ N O

0~
C ~ '_ ~ mN=

c0 p M Q. O ~ ~ O ~
N ~
O
t~
N

N E ~ O >. ~ " C ~'' C~ O
c4 ~
~
cO
N

MOCOOOr00 N N ~ N ' ~.
..r I~. O b I~
h-h-I~

~ D I- U D I- v C
I- O

a E

a~
X ~ ~ .OC s r i lJJ CI r :
O
~-N
M
d' Mo4027.
Le A 29,463 ~,~.~..'.~~2j * w x ;
Q

ro ~ ~ 0 0 e ~ ~ ~ o d r o ' a ~C~ o O o 0 O

H

'r .,.e ro a~

M O f~ N

M N N c T~ .sr X O O O O O

!JJ

x d t ~ N N

t ~

N
N O O O O O . V

E LJ
~

. ~ I

O CT' w ~ r r ~ O O O O
et' ~ x A

s m .

n~

' ' o no co ao r. ~ o a a ,~.-r. ~- .- .r ~c~ 0 0 0 ~ o w o ~ o a Pi ~ C

~ ro r d-~

~ b e-~ CV r 4J r ~ O O O O O .
N

U

O

U!

ro r ~ i CO (O CO CO r-O

66~ >dO

r- O O O O O

W

C ~ b _ ~ ~ ~
~

ro .

C

O 'r~

V ~ ~ u7 ~ ~ +~O

~ N M ~ (p F- v-rG.

(n f- ~~

Mo4027.
Le A 29,463 EXAMPLES
Example 1: (Semiprepolymer process) In a 2 liter face-ground flask equipped with a stirrer and reflux condenser, 770 g hexane diol polycarbonate (having an OH number of 53.8 and a functionality of 2) and 440 g poly-e-caprolac-tone/polydimethyl siloxane block copolymer (i.e. Tegomer 6110~) (having an OH number of 56.1 and a functionality of 2) were dehy-drated for 1 hour at 120°C/14 mbar. 0.11 g dibutyl tin dilaurate and 782.8 g 4,4'-diisocyanatodicyclohexyl methane containing approx.
20% by weight of the trans,trans isomer were then introduced and the mixture was stirred at 120°C. An NCO value of 9.72% by weight was reached after 3 hours. 8.8 g ethylene-bis-stearyl amide and 11.0 g 2,6-ditert.butyl cresol (ionol) were then dissolved and 207.2 g butane-1,4-diol were added.
After homogenization, the mixture was poured onto Teflon trays and heated for 12 hours at 100°C. The sheet obtained was size reduced, homogenized by extrusion and injection-molded to test specimens.
The product had the following properties:
Hardness (Shore A) 91 Modules 100% 10.5 [Nmm ZJ
Modules 300% 28 [Nmm a]
Ultimate tensile stress 48.5 [Nmm'Zj Elongation at break 395%
Preliminary softening at 22°C
Example 2:
A mixture of 787.5 g polytetramethylene glycol (Terathane 2000 (having an OH number of 56.1, and a functionality of 2) and 450 g poly-e-caprolactone/polydimethyl siloxane block copolymer Mo4027 Le A 29,463 ~;~.~.~.9~~

(Tegomer 6110 (having an OH number of 56.1, and a functionality of 2) was dehydrated as described hereinabove in Example 1 and prepolymerized with 0.11 g dibutyl tin dilaurate and 803 g 4,4'-diisocyanatodicyclohexyl methane to an NCO content of 9.74% by weight. 9 g ethylene-bis-stearyl amide, 11.25 g 2,6-ditert.butyl cresol and 0.11 g dibutyl tin dilaurate were dissolved and the prepolymer was chain-extended with 209.5 g butane-1,4-dioi. After processing to test specimens, the following properties were determined:
Properties:
Hardness (Shore 86 A) Modulus 100% 8.9 [Nmm'xj Modulus 300% 16.2 [Nmm-2]

Ultimate tensile stress43.3 [Nmm'2j Elongation at break 510%
Preliminary softening at 33.5°C
Example 3:
A mixture of 1149.5 g polytetramethyiene glycol 2000 (Terathane 2000 (having an OH number of 56.1 and a functionality of 2) and 60.5 g poly-e-caprolactone/polydimethyl siloxane block copolymer (Tegomer 6110 (having an OH number of 56.1 and a functionality of 2) was dehydrated and prepolymerized with 0.11 g dibutyl tin dilaurate and 783.28 g 4,4'-diisocyanatodicyclohexyl meth-ane at 120°C to an NW content of 10.03°~ by weight. After the addition of 11 g 2,6-ditert.butyl cresol, 0.11 g dibutyl tin dilaurate and 8.8 g ethylene bis-stearyl amide, the product was chain-extended with 206.7 g butane-1,4-diol.
Mo4027 Le A 299463 s~~~~~~~

Properties:
Hardness (Shore A) 86 Modules 100% 8.9 [Nmm'Z]
Modules 300% 16.2 [Nmm'2]
Ultimate tensile stress 43.3 [Nmm'Z]
Elongation at break 510%
Preliminary softening at 28°C
Example 4:
In a 2 liter face-ground flask equipped with an anchor stirrer and reflex condenser, a mixture of 1149.5 g hexane diol polycarbonate (r0esmophen 2020 (having an OH number of 53.8 and a functionality of 2) and 60.5 g poly-e-caprolactone/polydimethyl siloxane block copolymer (Tegomer 6110 (having an OH number of 56.1 and a functionality of 2) was dehydrated for 1 hour at 120°C/14 mbar. 785 g 4,4'-diisocyanatodicyclohexyl methane (trans,trans content: approx. 20% by weight) and 0.11 g dibutyl tin dilaurate were then added and the mixture was prepolymerized at 120°C. 11 g 2,6-ditert.butyl cresol, 8.8 g ethylene bis-stearyl amide and 0.11 g dibutyl tin dilaurate were dissolved and the prepolymer was chain-extended with 205.0 g butane-1,4-diol.
Properties:
Hardness (Shore A) 91 Modules 100°~ 11.6 [Nmm a]
Modules 300% 39.1 [Nmm Z]
Ultimate tensile stress 56.9 [Nmm'2]
Elongation at break 355%
Preliminary softening at 19°C
Mo4027 LeA 29,463 1~.~.~2~

Example 5: (Comparison Example without Tegomer 6110 1320 g polytetramethylene glycol 2000 (Terathane 2000 (having an OH number of 50.1 and a functionality of 2) were dehy-drated as in Example 1 and polymerized with 718.7 g 4,4'-diisocyanatodicyclohexyl methane and 0.11 g dibutyl tin dilaurate to an NGO content of 8.5% by weight. After the addition of 0.11 g dibutyl fin dilaurate, 3.74 g ethylene bis-stearyl amide and 22 g 2,6-ditert.butyl cresol, the product was chain-extended with 161.3 g butane-1,4-diol. After processing to test specimens, the material had the following properties:
Hardness (Shore A) 80 Modulus 100% 6.2 [Nmm'Z]
Modulus 300% 11.3 [Nmm 2j Ultimate tensile stress 36.7 [Nmm'Z]
Elongation at break 585%
Preliminary softening: none Example 6: (Comparison Example) A mixture of 1102.4 g polytetramethylene glycol 2000 (Terathane 2000 (having an OH number of 56.1 and a functionality of 2) and 107.6 g polydimethyl siloxane 2000 (Tegomer 2311 (having a OH number of 46 and a functionality of 2) was dehydrated for 1 hour at 120°C and prepolymerized with 782.24 g 4,4'-diisocyanatodicyclohexyl methane and 0.11 g dibutyl tin dilaurate to an NCO content of 10.08% by weight.
After the addition of 11 g 2,6-tert.butyl cresol, 0.11 g dibutyl tin dilaurate and 8.8 g ethylene bis-stearyl amide, the product was chain-extended with 207.5 g butane-1,4-diol. After curing and processing, the material had the following properties:
Mo4027 Le~1 29, 463 Y~

Hardness (Shore A) 88 Modules 100% 8.9 [Nmm'2]
Modules 300% 14.7 [Nmm'Z]
Ultimate tensile stress 38.6 [Nmm-Z]
Elongation at break a63%
Preliminary softening: none Although the invention has been described in detail in the foregoing for the purpose of illustration, it is to be understood that such detail is solely far that purpose and that variations can be made therein by those skilled in the ark without departing from the spirit and scope of the invention except as it may be limited by the claims.
Mo4027 Le A 29,463

Claims (10)

1. Segmented thermoplastic polyurethanes modified with siloxane block copolymers and based on relatively high molecular weight dihydroxy compounds, diisocyanates, and difunctional chain extenders, comprising the reaction product of a) a relatively high molecular weight dihydroxy compound having a molecular weight of from 800 to 8,000;
b) at least one isocyanate corresponding to the general for-mula:
OCN-Z-NCO, wherein Z represents: a difunctional organic radical;
c) at least one difunctional chain extender;
and d) at least one substantially linear hydroxy-terminated polyol corresponding to the following formula:
wherein x represents: an integer of from 1 to 30, y represents: an integer of from 1 to 50, z represents: an integer of from 2 to 4, R1 represents: a C1-6 alkyl group or a phenyl group, and R2 represents: a C2-8 alkylene group.
2. The segmented thermoplastic polyurethanes of Claim 1, wherein said component a) is selected from the group consisting of i) a polyether, ii) a polycarbonate, and iii) mixtures thereof.
3. The segmented thermoplastic polyurethanes of Claim 2 wherein said component a) has a molecular weight of from 1,000 to 4,000.
4. The segmented thermoplastic polyurethanes of Claim 1 wherein said component b) corresponds to the general formula:
OCN-Z-NCO, wherein Z represents: a cycloaliphatic radical.
5. The segmented thermoplastic polyurethanes of Claim 1, wherein said component c) is selected from the group consisting of i) an aliphatic diol containing from 2 to 14 carbon atoms, and ii) a cycloaliphatic diamine containing from 2 to 14 carbon atoms.
6. The segmented thermoplastic polyurethanes of Claim 5, wherein said component c) is selected from the group consisting of ethylene glycol, butane diol, hexane diol, 1,4-di(b-hydroxyethyl)-hydroquinone, isophorone diamine, and 4,4'-dicyclohexylmethane diamine.
7. The segmented thermoplastic polyurethanes of Claim 1, wherein said y represents an integer of from 20 to 40, in said formula of said substantially linear hydroxy-terminated polyol.
8. The segmented thermoplastic polyurethanes of Claim 7, wherein said y represents an integer of from 25 to 35, in said formula of said substantially linear hydroxy-terminated polyol.
9. The segmented thermoplastic polyurethanes of Claim 1, wherein said substantially linear hydroxy-terminated polyol is present in a quantity of 1 to 20% by weight, based on 100% by weight of components a), b), c) and d).
10. A process for the production of the modified thermoplastic polyurethanes of Claim 1, wherein said components a) to d) are reacted in stages or by a one-shot process, optionally in the presence of catalysts and additives at an NCO:OH ratio of 1:0.85 to 1:1.2.
CA002111925A 1992-12-23 1993-12-20 Thermoplastic polyurethanes modified by siloxane block copolymers Expired - Fee Related CA2111925C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP4243799.7 1992-12-23
DE4243799A DE4243799A1 (en) 1992-12-23 1992-12-23 Siloxane block copolymer modified thermoplastic polyurethanes

Publications (2)

Publication Number Publication Date
CA2111925A1 CA2111925A1 (en) 1994-06-24
CA2111925C true CA2111925C (en) 2004-09-14

Family

ID=6476357

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002111925A Expired - Fee Related CA2111925C (en) 1992-12-23 1993-12-20 Thermoplastic polyurethanes modified by siloxane block copolymers

Country Status (4)

Country Link
US (1) US5430121A (en)
EP (1) EP0603679B1 (en)
CA (1) CA2111925C (en)
DE (2) DE4243799A1 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19524653A1 (en) * 1994-12-23 1996-06-27 Ruesch Willy Ag Placeholder for placement in a body tube
US5674277A (en) * 1994-12-23 1997-10-07 Willy Rusch Ag Stent for placement in a body tube
DE4447101A1 (en) * 1994-12-29 1996-07-04 Freiburghaus Andreas U Bodies for tube-like passageways e.g. veins and arteries
JP2000506554A (en) * 1995-12-22 2000-05-30 ノバルティス アクチエンゲゼルシャフト Polyurethanes made from polysiloxane / polyol macromers
US6521164B1 (en) 1996-02-06 2003-02-18 Parker-Hannifin Corporation Injection-moldable thermoplastic polyurethane elastomer
AUPO251096A0 (en) * 1996-09-23 1996-10-17 Cardiac Crc Nominees Pty Limited Polysiloxane-containing polyurethane elastomeric compositions
US6846893B1 (en) * 1996-10-23 2005-01-25 Minnesota Mining And Manufacturing Company Polymer mixtures containing polydiorganosiloxane urea-containing components
US6221997B1 (en) 1997-04-28 2001-04-24 Kimberly Ann Woodhouse Biodegradable polyurethanes
AUPO700297A0 (en) * 1997-05-26 1997-06-19 Cardiac Crc Nominees Pty Limited Silicon-based polycarbonates
AUPQ170799A0 (en) * 1999-07-20 1999-08-12 Cardiac Crc Nominees Pty Limited Shape memory polyurethane or polyurethane-urea polymers
DE10113980A1 (en) * 2001-03-22 2002-10-02 Consortium Elektrochem Ind Silane-terminated polydiorganosiloxane-urethane copolymer
GB0122393D0 (en) * 2001-09-17 2001-11-07 Polybiomed Ltd Treating metal surfaces to enhance bio-compatibility
DE10243965A1 (en) * 2002-09-20 2004-04-01 Adiam Life Science Ag Process for the production of biocompatible polyurethanes
US8870814B2 (en) * 2003-07-31 2014-10-28 Boston Scientific Scimed, Inc. Implantable or insertable medical devices containing silicone copolymer for controlled delivery of therapeutic agent
GB0401202D0 (en) * 2004-01-20 2004-02-25 Ucl Biomedica Plc Polymer for use in conduits and medical devices
US7638091B2 (en) * 2004-07-02 2009-12-29 Sabic Innovative Plastics Ip B. V. Methods of sterilizing polycarbonate articles and methods of manufacture
US7494665B1 (en) 2004-07-30 2009-02-24 Advanced Cardiovascular Systems, Inc. Polymers containing siloxane monomers
US20060142486A1 (en) * 2004-12-23 2006-06-29 Derudder James L Thermoplastic polycarbonate compositions, articles made therefrom and method of manufacture
US7432327B2 (en) * 2004-12-30 2008-10-07 Sabic Innovative Plastics Ip B.V. Transparent polymeric compositions comprising polysiloxane-polycarbonate copolymer, articles made therefrom and methods of making same
US7498401B2 (en) * 2005-03-03 2009-03-03 Sabic Innovative Plastics Ip B.V. Thermoplastic polycarbonate compositions, articles made therefrom and method of manufacture
KR100878883B1 (en) 2006-03-16 2009-01-15 호성케멕스 주식회사 Moisture-permeable and waterproof thermoplastic polyurethane for extrusion molding
US20120150131A1 (en) * 2010-12-09 2012-06-14 Teleflex Medical Incorporated Polymer for Controlling Delivery of Bioactive Agents and Method of Use
CA2876356C (en) 2012-06-12 2020-07-14 Basf Se Thermoplastic polyurethane composition
KR20170109902A (en) * 2016-03-22 2017-10-10 현대자동차주식회사 Thermoplastic polyurethane resin composition enhanced texture and durability and producing method thereof
US11746181B2 (en) * 2017-11-17 2023-09-05 Piper Access, Llc Alcohol-resistant siliconized polycarbonate polyurethanes and medical devices incorporating the same
WO2021026108A1 (en) * 2019-08-05 2021-02-11 Lubrizol Advanced Materials, Inc. Thermoplastic polyurethane and process for making a thermoplastic polyurethane and components thereof
KR102553303B1 (en) * 2020-07-08 2023-07-07 주식회사 아이센스 Functionalized thermoplastic polyurethane, method for preparing the same, method for preparing high performance composite in medical application and medical device comprising the same
CN114891184B (en) * 2022-06-09 2024-01-26 福建汇得新材料有限公司 Organosilicon modified polyurethane elastomer and preparation method and application thereof
CN115368531A (en) * 2022-07-09 2022-11-22 苏州净涵新材料科技有限公司 Self-lubricating stain-resistant thermoplastic polyurethane elastomer and preparation method thereof
WO2024016270A1 (en) * 2022-07-21 2024-01-25 Dow Global Technologies Llc Polyurethane composition

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3562352A (en) * 1968-09-06 1971-02-09 Avco Corp Polysiloxane-polyurethane block copolymers
US3975350A (en) * 1972-08-02 1976-08-17 Princeton Polymer Laboratories, Incorporated Hydrophilic or hydrogel carrier systems such as coatings, body implants and other articles
DE2817457A1 (en) * 1978-04-21 1979-10-31 Bayer Ag THERMOPLASTIC POLYURETHANE FOR PROCESSING IN EXTRUDERS AND / AND ON CALENDARS
US4675361A (en) * 1980-02-29 1987-06-23 Thoratec Laboratories Corp. Polymer systems suitable for blood-contacting surfaces of a biomedical device, and methods for forming
GB2140438B (en) * 1980-02-29 1985-06-05 Thoratec Lab Corp Blood compatible polymer mixture
US4454309A (en) * 1980-11-12 1984-06-12 Tyndale Plains-Hunter, Ltd. Polyurethane polyene compositions
EP0068385B1 (en) * 1981-06-22 1986-09-24 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Thermoplastic elastomers for medical use as moulded articles brought into direct contact with blood
FR2513644B1 (en) * 1981-09-30 1985-06-21 Rhone Poulenc Spec Chim POLYSILOXANIC AND POLYURETHANIC SEQUENCE COPOLYMERS USED IN PARTICULAR AS THERMOPLASTIC ELASTOMERS
JPS5978236A (en) * 1982-10-28 1984-05-07 Toagosei Chem Ind Co Ltd Production of vinyl-polymerizable high-molecular straight-chain silicone monomer
JPS60252617A (en) * 1984-05-28 1985-12-13 Daicel Chem Ind Ltd Thermoplastic and antithrombotic elastomer
WO1986001813A1 (en) * 1984-09-21 1986-03-27 Raychem Corporation Multiple phase polymeric compositions
AU5302086A (en) * 1985-01-04 1986-07-29 Thoratec Laboratories Corp. Compositions that soften at predetermined temperatures and the method of making same
US4647643A (en) * 1985-11-08 1987-03-03 Becton, Dickinson And Company Soft non-blocking polyurethanes
JP2819410B2 (en) * 1987-01-22 1998-10-30 大日本インキ化学工業株式会社 Method for producing thermoplastic polyurethane resin for moisture-permeable and waterproof material
US4939007A (en) * 1988-03-07 1990-07-03 Becton, Dickinson And Company Article having a hemocompatible surface

Also Published As

Publication number Publication date
DE4243799A1 (en) 1994-06-30
EP0603679A3 (en) 1995-08-02
EP0603679B1 (en) 1998-07-15
DE59308779D1 (en) 1998-08-20
US5430121A (en) 1995-07-04
EP0603679A2 (en) 1994-06-29
CA2111925A1 (en) 1994-06-24

Similar Documents

Publication Publication Date Title
CA2111925C (en) Thermoplastic polyurethanes modified by siloxane block copolymers
CA1335317C (en) Fluorinated polyetherurethanes and medical devices therefrom
US4447590A (en) Extrudable polyurethane for prosthetic devices prepared from a diisocyanate, a polytetramethylene ether polyol and 1,4 butane diol
EP0595500B1 (en) Non-swelling polyurethane, softenable by contact with a liquid
KR100515727B1 (en) Waterborne polyurethane having film properties comparable to rubber
US4935480A (en) Fluorinated polyetherurethanes and medical devices therefrom
US5516857A (en) Thermoplastic urethane elastomeric alloys
JPH03157416A (en) Polyurethane for flexible fuel container
AU2003200443A1 (en) A process for the preparation of soft, low-shrinkage, thermoplastic polyurethane elastomers which can be easily released from the mold
US5250649A (en) Melt processable polyurethaneurea copolymers and method for their preparation
JP2008266587A (en) Method for producing molded shape memory article having wide application range
Ulubayram et al. Polyurethanes: effect of chemical composition on mechanical properties and oxygen permeability
JPH0317114A (en) Melt fabricatable polyure- thaneurea polymers and their preparation
JPH03119018A (en) Thermoplastic polyurethane, manufacture thereof, and manufacture of medical equipment
US3678009A (en) Thermocurable crystalline polyurethanes based on branched polyesters
US20030036621A1 (en) Process for making bloom-free thermoplastic polyurethane compositions
EP4069761A1 (en) A medical tubing comprising thermoplastic polyurethane
JP3684567B2 (en) Method for producing thermoplastic polyurethane resin
JP3339088B2 (en) Balloon material for catheter and balloon for catheter using the same
JPH03115317A (en) Melt-processable polyurethane-urea and its manufacture
JPH09104736A (en) Medical polyurethane composition and molded product
JP3775522B2 (en) Polyurethane
JP3138305B2 (en) Polyurethane, polyurethane fiber and polyester carbonate diol used for the polyurethane
JP2001122939A (en) Ester-based elastomer
JPS5856530B2 (en) Manufacturing method of polyurethane elastomer

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed